STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...

The FDA granted fast track designation to TRE-515 plus radioligand therapy for treating PSMA-positive metastatic ...

Men with non-metastatic forms are likely to live 'for many years' after diagnosis when active surveillance and other NCCN ...

PEOPLE and Verywell Health joined forces to share facts about prostate cancer, plus unique perspectives from men with the ...

Prostate cancer can be difficult to detect in its beginning stages — here's what to look out for to help catch it before it ...

Patients with nonmetastatic prostate cancer treated according to NCCN Guidelines are more likely to die of other natural ...

Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate ...

A new study by University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about ...

Prostate cancer is a stealthy disease with no attention-grabbing symptoms at first. It’s also a private and sensitive topic that men don’t want to discuss. But for men age 40 and older, it’s a good ...

A breakthrough in prostate cancer treatment is now available in Cincinnati, and it changed one patient's life faster than he ...

Metastatic prostate cancer is a type of cancer that began in the prostate gland and has spread to other areas of the body, ...

Prostate cancer focal therapies include cryotherapy, irreversible electroporation ablation (IRE), & high-intensity focused ultrasound (HIFU).